A Case Report with Severe Thrombocytopenia Induced by Axitinib

Axitinib is an oral, second-generation tyrosine kinase inhibitor that is selective for vascular endothelial growth factor receptors (VEGFR). This agent is approved as monotherapy or in combination with immune checkpoint inhibitors for the treatment of metastatic renal cell carcinoma. Axitinib is ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Koksal, Ulkuhan I., Goffin, Janeiro Valle, Lewis, Brian, Sartor, Oliver A., Belyaeva, Elizaveta, Socola, Francisco, Barata, Pedro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029294/
https://www.ncbi.nlm.nih.gov/pubmed/32089908
http://dx.doi.org/10.1155/2020/7520783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029294/
https://www.ncbi.nlm.nih.gov/pubmed/32089908
http://dx.doi.org/10.1155/2020/7520783

Ejemplares similares